Back to Search Start Over

LINE-1 ORF1p as a candidate biomarker in high grade serous ovarian carcinoma

Authors :
Sho Sato
Michael Gillette
Pamela R. de Santiago
Eric Kuhn
Michael Burgess
Kristen Doucette
Yi Feng
Carlos Mendez-Dorantes
Paul J. Ippoliti
Sara Hobday
Marilyn A. Mitchell
Kai Doberstein
Stefan M. Gysler
Michelle S. Hirsch
Lauren Schwartz
Michael J. Birrer
Steven J. Skates
Kathleen H. Burns
Steven A. Carr
Ronny Drapkin
Source :
Scientific Reports, Vol 13, Iss 1, Pp 1-15 (2023)
Publication Year :
2023
Publisher :
Nature Portfolio, 2023.

Abstract

Abstract Long interspersed element 1 (LINE-1) open reading frame 1 protein (ORF1p) expression is a common feature of many cancer types, including high-grade serous ovarian carcinoma (HGSOC). Here, we report that ORF1p is not only expressed but also released by ovarian cancer and primary tumor cells. Immuno-multiple reaction monitoring-mass spectrometry assays showed that released ORF1p is confidently detectable in conditioned media, ascites, and patients’ plasma, implicating ORF1p as a potential biomarker. Interestingly, ORF1p expression is detectable in fallopian tube (FT) epithelial precursors of HGSOC but not in benign FT, suggesting that ORF1p expression in an early event in HGSOC development. Finally, treatment of FT cells with DNA methyltransferase inhibitors led to robust expression and release of ORF1p, validating the regulatory role of DNA methylation in LINE-1 repression in non-tumorigenic tissue.

Subjects

Subjects :
Medicine
Science

Details

Language :
English
ISSN :
20452322
Volume :
13
Issue :
1
Database :
Directory of Open Access Journals
Journal :
Scientific Reports
Publication Type :
Academic Journal
Accession number :
edsdoj.4b43d6de805a4bc5b6fd254961a19c5f
Document Type :
article
Full Text :
https://doi.org/10.1038/s41598-023-28840-5